Incretin-Based Therapies: Viewpoints on the way to consensus

Gelijkaardige items

• Viewpoints on the Way to the Consensus Session: Where does insulin resistance start? The adipose tissue
  door: Iozzo, Patricia
  Gepubliceerd in: (2009)
• Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
  door: Perseghin, Gianluca
  Gepubliceerd in: (2009)
• Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
  door: Holst, Jens J., et al.
  Gepubliceerd in: (2011)
• The evolving place of incretin-based therapies in type 2 diabetes
  door: Gallwitz, Baptist
  Gepubliceerd in: (2010)
• Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy
  door: Garber, Alan J.
  Gepubliceerd in: (2009)